112 related articles for article (PubMed ID: 15920491)
1. RBM15 and MKL1 mutational screening in megakaryoblastic leukemia cell lines and clinical samples.
Kawaguchi H; Hitzler JK; Ma Z; Morris SW
Leukemia; 2005 Aug; 19(8):1492-4. PubMed ID: 15920491
[No Abstract] [Full Text] [Related]
2. TERT promotor variant associated with poor clinical outcome in a patient with novel RBM15-MKL1 fusion-positive pediatric acute megakaryoblastic leukemia.
Langenberg-Ververgaert K; Renzi S; Fuligni F; Davidson S; Abdelhaleem M; Lo W; Malkin D; Shlien A; Shago M; Villani A; Abla O
Pediatr Blood Cancer; 2021 Jan; 68(1):e28542. PubMed ID: 32743872
[No Abstract] [Full Text] [Related]
3. Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia.
Ma Z; Morris SW; Valentine V; Li M; Herbrick JA; Cui X; Bouman D; Li Y; Mehta PK; Nizetic D; Kaneko Y; Chan GC; Chan LC; Squire J; Scherer SW; Hitzler JK
Nat Genet; 2001 Jul; 28(3):220-1. PubMed ID: 11431691
[TBL] [Abstract][Full Text] [Related]
4. Whole-exome sequencing identifies a novel somatic mutation in MMP8 associated with a t(1;22)-acute megakaryoblastic leukemia.
Kim Y; Schulz VP; Satake N; Gruber TA; Teixeira AM; Halene S; Gallagher PG; Krause DS
Leukemia; 2014 Apr; 28(4):945-8. PubMed ID: 24157583
[No Abstract] [Full Text] [Related]
5. RBM15-MKL1 (OTT-MAL) fusion transcript in an adult acute myeloid leukemia patient.
Hsiao HH; Yang MY; Liu YC; Hsiao HP; Tseng SB; Chao MC; Liu TC; Lin SF
Am J Hematol; 2005 May; 79(1):43-5. PubMed ID: 15849773
[TBL] [Abstract][Full Text] [Related]
6. Hemophagocytosis by leukemic megakaryoblasts in acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1.
Wiseman DH; Bonney DK; Wynn RF
J Pediatr Hematol Oncol; 2012 Oct; 34(7):576-80. PubMed ID: 22469944
[TBL] [Abstract][Full Text] [Related]
7. New hPSC-based human models to study pediatric Acute Megakaryoblastic Leukemia harboring the fusion oncogene RBM15-MKL1.
Ayllón V; Vogel-González M; González-Pozas F; Domingo-Reinés J; Montes R; Morales-Cacho L; Ramos-Mejía V
Stem Cell Res; 2017 Mar; 19():1-5. PubMed ID: 28412998
[TBL] [Abstract][Full Text] [Related]
8. Acute megakaryoblastic leukemia with a four-way variant translocation originating the RBM15-MKL1 fusion gene.
Torres L; Lisboa S; Vieira J; Cerveira N; Santos J; Pinheiro M; Correia C; Bizarro S; Almeida M; Teixeira MR
Pediatr Blood Cancer; 2011 May; 56(5):846-9. PubMed ID: 21370421
[TBL] [Abstract][Full Text] [Related]
9. Detection of RBM15-MKL1 fusion was useful for diagnosis and monitoring of minimal residual disease in infant acute megakaryoblastic leukemia.
Takeda A; Shimada A; Hamamoto K; Yoshino S; Nagai T; Fujii Y; Yamada M; Nakamura Y; Watanabe T; Watanabe Y; Yamamoto Y; Sakakibara K; Oda M; Morishima T
Acta Med Okayama; 2014; 68(2):119-23. PubMed ID: 24743787
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic significance of chimeric fusion gene analysis in pediatric acute megakaryoblastic leukemia].
Tamefusa K; Fukutake K; Ishida H; Tamura A; Endo M; Hamamoto K; Koga Y; Yamada M; Kanamitsu K; Fujiwara K; Washio K; Shimada A
Rinsho Ketsueki; 2019; 60(2):99-105. PubMed ID: 30842387
[TBL] [Abstract][Full Text] [Related]
11. Acute megakaryoblastic leukaemia with t(1;22)(p13·3;q13·1)/RBM15-MKL1 in an adult patient following a non-mediastinal germ cell tumour.
Saito Y; Makita S; Chinen S; Kito M; Fujino T; Ida H; Hosoba R; Tanaka T; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Miyagi-Maeshima A; Matsushita H; Izutsu K
Br J Haematol; 2020 Sep; 190(6):e329-e332. PubMed ID: 32572949
[No Abstract] [Full Text] [Related]
12. Fusion of OTT to BSAC results in aberrant up-regulation of transcriptional activity.
Sawada T; Nishiyama C; Kishi T; Sasazuki T; Komazawa-Sakon S; Xue X; Piao JH; Ogata H; Nakayama J; Taki T; Hayashi Y; Watanabe M; Yagita H; Okumura K; Nakano H
J Biol Chem; 2008 Sep; 283(39):26820-8. PubMed ID: 18667423
[TBL] [Abstract][Full Text] [Related]
13. Bi-allelic deletions within 13q14 and transient trisomy 21 with absence of GATA1s in pediatric acute megakaryoblastic leukemia.
Massaro SA; Bajaj R; Pashankar FD; Ornstein D; Gallagher PG; Krause DS; Li P
Pediatr Blood Cancer; 2011 Sep; 57(3):516-9. PubMed ID: 21538823
[TBL] [Abstract][Full Text] [Related]
14. Acute megakaryoblastic leukemia with t(1;22)(p13.3;q13.1); RBM15-MKL1 mimicking hepatoblastoma in an infant: The role of karyotype in differential diagnosis.
Marques-Piubelli ML; Cordeiro MG; Cristofani L; Barroso RS; Paes VR; Castelli JB; Rodrigues Pereira Velloso ED
Pediatr Blood Cancer; 2020 Mar; 67(3):e28111. PubMed ID: 31802626
[No Abstract] [Full Text] [Related]
15. Rbm15-Mkl1 interacts with the Setd1b histone H3-Lys4 methyltransferase via a SPOC domain that is required for cytokine-independent proliferation.
Lee JH; Skalnik DG
PLoS One; 2012; 7(8):e42965. PubMed ID: 22927943
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional activity of megakaryoblastic leukemia 1 (MKL1) is repressed by SUMO modification.
Nakagawa K; Kuzumaki N
Genes Cells; 2005 Aug; 10(8):835-50. PubMed ID: 16098147
[TBL] [Abstract][Full Text] [Related]
17. Megakaryoblastic leukemia factor-1 gene in the susceptibility to coronary artery disease.
Hinohara K; Nakajima T; Yasunami M; Houda S; Sasaoka T; Yamamoto K; Lee BS; Shibata H; Tanaka-Takahashi Y; Takahashi M; Arimura T; Sato A; Naruse T; Ban J; Inoko H; Yamada Y; Sawabe M; Park JE; Izumi T; Kimura A
Hum Genet; 2009 Oct; 126(4):539-47. PubMed ID: 19513752
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
[TBL] [Abstract][Full Text] [Related]
19. A novel fusion of RBM6 to CSF1R in acute megakaryoblastic leukemia.
Gu TL; Mercher T; Tyner JW; Goss VL; Walters DK; Cornejo MG; Reeves C; Popova L; Lee K; Heinrich MC; Rush J; Daibata M; Miyoshi I; Gilliland DG; Druker BJ; Polakiewicz RD
Blood; 2007 Jul; 110(1):323-33. PubMed ID: 17360941
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the tumor suppressor Smad2 in acute lymphoid and myeloid leukemia.
Wieser R; Gruber B; Rieder H; Fonatsch C
Leukemia; 1998 Jul; 12(7):1114-8. PubMed ID: 9665198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
